Biology and Molecular Biology of the Evolution of Macrophage-Tropic HIV-1
巨噬细胞趋向性 HIV-1 进化的生物学和分子生物学
基本信息
- 批准号:10882245
- 负责人:
- 金额:$ 38.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-25 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS dementiaAddressAffinityAlanineAmino AcidsAttenuatedAutopsyBindingBiological AssayBiologyBrainBypassCCR5 geneCD4 Positive T LymphocytesCell NucleusCell surfaceCellsCentral Nervous SystemChromosome MappingConsensusDataEnvironmentEpidemicEvolutionFaceFounder EffectGenetic DeterminismGenetic TranscriptionHIV-1HIV-2HumanImpairmentIndividualInfectionInflammatoryIntegration Host FactorsKnowledgeLengthLymphoidMacrophageMapsMicrogliaModelingMolecularMolecular BiologyMolecular CloningMolecular ConformationMyeloid CellsNatureNeurologicOrganOther GeneticsPathogenesisPathogenicityPathway interactionsPatternPhenotypePopulationPrimate LentivirusesProteinsRecombinantsRoleSamplingScanningSolidSystemT-Cell ActivationT-LymphocyteTestingTropismUnmarried personVariantViralVirusVirus DiseasesVirus ReplicationWorkcell typedensityenv Gene Productsenv Genespressurereceptortranscriptome sequencing
项目摘要
Project Abstract
The biology, evolution, and pathogenesis of macrophage-tropic HIV-1 is poorly understood. Historically, all R5
(CCR5-tropic) HIV-1 strains were considered macrophage-tropic. We now know that the wild type/normal form
of HIV-1 requires a high density of CD4 for entry, thus directing infections to CD4+ T cells, which express high
densities of CD4, and avoiding infection of macrophages, which express low densities of CD4. Macrophage
tropism represents an evolutionary path along which the virus evolves the ability to more efficiently use a low
density of CD4 for entry, allowing myeloid cells to now become targets for replication. This evolutionary path is
followed most commonly within the CNS, where CD4+ T cells are rare, and evolution of this phenotype is
associated with HIV-associated dementia. Several attempts have been made to map genetic determinants of
macrophage tropism and paradoxically these have often been identified as the consensus amino acid in the R5
T-tropic virus population. Also, other than inferring better binding to CD4, nothing is known about the molecular
mechanisms of how the Env protein evolves to become macrophage-tropic. Similarly, how HIV-1 colonizes the
brain to establish a compartmentalized infection is largely obscure. Little is known about how selective pressures
within myeloid cells may select for additional evolution beyond the entry phenotype, where such pressure may
have selected for Vpx in other primate lentiviruses. Answers to these questions will inform the search for a latent
reservoir in the CNS, which may ultimately be important for a successful HIV-1 cure. In this application we provide
extensive preliminary data that start to address these questions and describe a body of work that will significantly
advance our knowledge of this most pathogenic evolutionary variant of HIV-1.
项目摘要
嗜巨噬细胞的HIV-1的生物学、进化和发病机制知之甚少。从历史上看,所有R5
(CCR 5嗜性)HIV-1毒株被认为是嗜巨噬细胞的。我们现在知道野生型/正常型
HIV-1的感染需要高密度的CD 4进入,从而将感染导向CD 4 + T细胞,这些细胞表达高水平的
CD 4密度,并避免感染表达低密度CD 4的巨噬细胞。巨噬
嗜性代表了一条进化路径,病毒沿着该路径沿着进化出更有效地利用低亲和力的能力。
CD 4的密度进入,使骨髓细胞现在成为复制的目标。这条进化之路是
其次是最常见的中枢神经系统,其中CD 4 + T细胞是罕见的,这种表型的演变是
与艾滋病相关的痴呆症。已经进行了几次尝试来绘制遗传决定因素,
巨噬细胞嗜性,矛盾的是,这些经常被鉴定为R5中的共有氨基酸。
T嗜性病毒群体。此外,除了推断与CD 4更好的结合外,对该分子还一无所知。
Env蛋白如何进化成嗜巨噬细胞的机制。同样,HIV-1如何在
大脑中建立分区感染的可能性很大程度上是模糊的。我们对选择性压力
在髓样细胞内的压力可能选择进入表型以外的额外进化,其中这种压力可能
已经在其他灵长类慢病毒中选择了Vpx。这些问题的答案将有助于寻找潜在的
中枢神经系统中的储存库,这最终可能对于成功治愈HIV-1很重要。在这个应用程序中,我们提供
广泛的初步数据,开始解决这些问题,并描述了一个机构的工作,将显着
推进了我们对这种最具致病性的HIV-1进化变体的认识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH BETH JOSEPH其他文献
SARAH BETH JOSEPH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH BETH JOSEPH', 18)}}的其他基金
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
- 批准号:
10379970 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
- 批准号:
10055342 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
- 批准号:
10188483 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Intersection of HIV, Opiods, and Amyloid Fibrils in a CNS Organoid Model
CNS 类器官模型中 HIV、阿片类药物和淀粉样原纤维的交集
- 批准号:
10594460 - 财政年份:2020
- 资助金额:
$ 38.22万 - 项目类别:
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates
携带临床相关 HIV-1 包膜的新型 SHIV 的开发和使用,用于检查非人类灵长类动物中枢神经系统中 HIV 的持续存在和根除情况
- 批准号:
10450183 - 财政年份:2019
- 资助金额:
$ 38.22万 - 项目类别:
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates
携带临床相关 HIV-1 包膜的新型 SHIV 的开发和使用,用于检查非人类灵长类动物中枢神经系统中 HIV 的持续存在和根除情况
- 批准号:
10018109 - 财政年份:2019
- 资助金额:
$ 38.22万 - 项目类别:
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates
携带临床相关 HIV-1 包膜的新型 SHIV 的开发和使用,用于检查非人类灵长类动物中枢神经系统中 HIV 的持续存在和根除情况
- 批准号:
10672903 - 财政年份:2019
- 资助金额:
$ 38.22万 - 项目类别:
Development and Use of Novel SHIVs Bearing Clinically Relevant HIV-1 Envs for Examining HIV Persistence and Eradication in the CNS of Nonhuman Primates
携带临床相关 HIV-1 包膜的新型 SHIV 的开发和使用,用于检查非人类灵长类动物中枢神经系统中 HIV 的持续存在和根除情况
- 批准号:
10219924 - 财政年份:2019
- 资助金额:
$ 38.22万 - 项目类别:
The Causes and Consequences of Complementation and Selfishness in Viruses
病毒中互补性和自私性的原因和后果
- 批准号:
7332810 - 财政年份:2007
- 资助金额:
$ 38.22万 - 项目类别:
The Causes and Consequences of Complementation and Selfishness in Viruses
病毒中互补性和自私性的原因和后果
- 批准号:
7487822 - 财政年份:2007
- 资助金额:
$ 38.22万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 38.22万 - 项目类别:
Research Grant